An antiviral drug (trade name Relenza©) which may shorten the time during which the symptoms of INFLUENZA are present. Oseltamivir has similar properties. It has been used as a public health measure at times when a significant epidemic occurs or is expected, but there remains uncertainty about its cost-effectiveness.